Empagliflozin impairs smooth muscle cell proliferation, accelerates endothelial regeneration, and prevents neointima formation by altered expression of the vasoactive peptide apelin
Event:
ESC Congress 2020
Topic:
Drugs, Drug Targets
Session:
Basic Science Vascular ePosters